NASDAQ · EVAX
Evaxion A/S American Depositary Share
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for EVAX: Nov 19, 2026
Evaxion A/S American Depositary Share is expected to report earnings on 11/19/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. The reported EPS for the same quarter last year was $0.73.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Fintel · RTTNews · The Motley Fool- Fintel · Oct 23, 7:12 AM EDTEvaxion Announces 89% Vaccine Target Precision and Sustained T-Cell and Clinical Responses at Three-Year Follow-Up in Phase 2 Trial with Personalized Cancer Vaccine EVX-01Evaxion A/S announced new three-year immune and clinical outcome data for its personalized cancer vaccine EVX-01 in patients with advanced melanoma. The data from the phase 2 trial demonstrates EVX-01 inducing an immune response in all patients, with 89% of its personalised vacci
- RTTNews · Oct 19, 3:42 PM EDTBiotech Stocks Rally: SLN Soars 125%, WORX Jumps 105%, IRON Gains 41%(RTTNews) – Biotech and healthcare stocks surged on Monday, drawing investor attention to Silence Therapeutics' $1.3 billion acquisition deal, SCWorx's new healthcare agreement and Disc Medicine's positive Phase 3 trial results. The developments highlighted acquisition-driven ups
- RTTNews · Oct 19, 4:22 AM EDTEvaxion Reports Durable Three-Year Responses With EVX-01 In Advanced Melanoma(RTTNews) – Patients who responded to treatment with EVX-01, a personalized cancer vaccine being developed by Evaxion A/S (EVAX), maintained their clinical responses through three years of follow-up in a Phase 2 study of advanced melanoma, with no tumor progression reported among
- RTTNews · Aug 20, 9:10 AM EDTEvaxion Reports Q2 Loss; Advances Cancer And Infectious Disease Vaccine Pipeline(RTTNews) – Evaxion A/S (EVAX), a clinical-stage TechBio company developing vaccines through its AI-Immunology platform, reported second-quarter 2026 financial results and provided an update on its vaccine development pipeline.
- RTTNews · Aug 17, 1:53 PM EDTEvaxion Adds AI-Designed EVX-05 Brain Cancer Vaccine; Discontinues EVX-03 Program(RTTNews) – Evaxion A/S (EVAX), a clinical-stage TechBio company developing vaccines using its AI-Immunology platform, announced the expansion and refocusing of its R&D pipeline with the addition of EVX-05, an off-the-shelf therapeutic vaccine candidate for glioblastoma.
- RTTNews · Jul 13, 2:46 AM EDTEvaxion Presents New Preclinical Data For The Cytomegalovirus Vaccine Program EVX-V1; Stock Up(RTTNews) – Evaxion A/S (EVAX), a clinical-stage TechBio company, presented new data supporting the multi-component concept of its investigational cytomegalovirus vaccine program EVX-V1.
- RTTNews · Jun 11, 4:00 AM EDTEvaxion Unveils New EVX-04 Data In AML Study; Stock Up(RTTNews) – Evaxion A/S (EVAX) has released new preclinical findings showing that its off-the-shelf therapeutic vaccine candidate EVX-04 successfully triggers targeted immune responses against acute myeloid leukemia (AML), reinforcing its potential as a new treatment approach for
- The Motley Fool · May 7, 3:42 PM EDTEvaxion (EVAX) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Apr 20, 4:44 AM EDTEvaxion To Present Dual Cancer Vaccine Updates At AACR 2026(RTTNews) – Evaxion A/S (EVAX) announced new Phase 2 trial of EVX-01, a personalized cancer vaccine for advanced melanoma, showing that the therapy achieved an 86% success rate in triggering tumor-specific immune responses.
- Fintel · Mar 10, 8:03 PM EDTJones Trading Initiates Coverage of Evaxion A (EVAX) with Buy RecommendationFintel reports that on March 10, 2026, Jones Trading initiated coverage of Evaxion A (NasdaqCM:EVAX) with a Buy recommendation. Analyst Price Forecast Suggests 238.08% Upside
- The Motley Fool · Mar 9, 11:37 AM EDTEvaxion (EVAX) Q4 2025 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Dec 1, 11:02 PM ESTAfter-Hours Spotlight: Jasper, NRx, Unicycive, Spruce, Evaxion, Solana, Protara Gain Post-Close(RTTNews) – Several biotechnology and pharmaceutical companies posted notable gains in after-hours trading on Monday, following a mix of corporate updates and upcoming event announcements.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Evaxion A/S American Depositary Share from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.